CSL Seqirus enters the UK flu market in 2027. Learn how this new player could diversify vaccine supply and boost national resilience against influenza.
Aaron Frost
·
Startup Culture: Thriving in 2026’s Economic Headwinds
Aaron Fitzpatrick
·
7 Mins Read
Startup struggling with brand traction? See 2026 tactics for audience segmentation, real-time data adjustments with Google Ads, and boosting conversion.
·
Iambic's 2026 IPO shows biotech's market challenges. Learn how companies like Iambic overcome investor skepticism and regulatory hurdles.
·
Founders: Understand 2025 cap table dilution risks from complex notes. Model scenarios to protect equity, control. 0.5% difference is $100k+.
·
Pharma startups face 2026 compliance demands. Learn why proactive regulatory strategy, allocating 15% R&D budget, and eCTD 4.0 are critical.
·
·
7 min read
Is AbbVie's aggressive biotech partnership model sustainable? Learn how its focus on late-stage assets, like Cerevel Therapeutics, shapes its future.
·
·
6 min read
2026 drug pricing debates threaten biotech startups. Learn how small firms can advocate for innovation and survive amidst calls for lower costs.
·
·
8 min read
Big Pharma spent $300M+ lobbying in 2025. See how this distorts policy, hurting biotech startups and innovation. What to watch next.
·
·
7 min read
How can pharma policy foster innovation? See how new rules aim to cut approval times by 15% for biotech startups by 2026.
·
·
8 min read
Struggling with B2B sales? See how AI cut Apex Solutions' sales cycle by 25%, boosting efficiency and forecasting accuracy by 15-20%.
·
·
8 min read
